NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Dalton Bioanalytics

Dalton Bioanalytics

Private
Los Angeles, CaliforniaHealthcare & Life Scienceshttps://www.daltonbioanalytics.com/

Last Round

Seed

Apr 1, 2020

Total Funding Raised

$500,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Dalton Bioanalytics is a biotechnology company that provides multi-omics analytical services using its proprietary Omni-MS platform to profile proteins, lipids, metabolites, and other molecules in a single assay.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

multi-omicscontract research organizationCRObiomarker discoveryliquid chromatography-mass spectrometryLC-MSproteomicsmetabolomicslipidomicsdrug development supportbioinformaticsdata-as-a-serviceomicsprecision medicinetranslational research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dalton Bioanalytics Comparables

Compare Dalton Bioanalytics with similar companies based on industry and business-model similarity.

Dalton Bioanalytics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sapient
89%
Metware Biotechnology
86%
Creative Proteomics
83%

Dalton Bioanalytics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 1, 2020
AcceleratorNov 1, 2019

Key People

Founding team and executive leadership

Seungjun Yeo

Co-founder and CEO

Founding Team

Dalton Bioanalytics Investors

Notable investors and investment history

Dalton Bioanalytics investors
InvestorRounds
IndieBioSeed, Accelerator
UCLA Anderson Venture AcceleratorSeed
SOSVAccelerator, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 3, 2026

    Monthly visitors increased 133% MoM, reaching 4.3K.

  • Feb 23, 2025

    Monthly visitors grew 399% MoM, reaching 888.

Dalton Bioanalytics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Dalton Bioanalytics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Dalton Bioanalytics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLos Angeles, California
Employee Range5
Year Founded2019
Last FundingApr 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.